Name: Next-generation Sequencing Services Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment &amp; Forecast (2023-2030)
SKU: 17493
Availability: InStock

Next-generation Sequencing Services Market – Report Overview

Pacific Business Consulting’s “Next-generation Sequencing Services Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Next-generation Sequencing Services market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Next-generation Sequencing Services market exceeded a valuation of over US$ 2.5 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 15.0% from 2023 to 2030. The market is expected to potentially surpass US$ 7.0 Billion by 2030.

Next-generation sequencing (NGS) technology is increasingly utilized for various applications, both conventional and non-conventional, enabling rapid and comprehensive insights at the genomic level. Continuous enhancements in automation, ancillary protocols, services, and analytical solutions have contributed to the growth of NGS in clinical workflows. This trend is expected to drive industry growth.

NGS, a breakthrough method for determining DNA/RNA sequences, plays a pivotal role in gaining comprehensive information on genomic sequences, either for the entire genome or specific regions connected to diseases or biological processes. Clinical NGS data analysis has witnessed an expanded market due to the growing demand for detailed genomic information.

NGS data analysis tools, encompassing sequence alignment, alignment visualization, gene prediction, and variation analysis, are employed to ascertain the nucleotide sequence of entire genomes or specific DNA/RNA portions. NGS platforms, utilizing massively parallel sequencing technology, contribute to high-throughput, scalability, and speed, ensuring the delivery of exceptionally accurate and high-quality data.

Technological advances in genomic-based bioinformatics tools present numerous growth opportunities. Recent advancements have made a substantial amount of genetic data accessible on web-based bioinformatics platforms, allowing research analysts or data scientists to compare and assess sequencing run quality, perform in-line control validation, and characterize immune receptor clones.

Understanding immune response traits, current illness scenarios, and therapeutic antigen presentation consequences can be inferred by analyzing the abundance and fluctuations of specific immune receptor clones in relation to treatment response and disease progression.

Genomic-based analyses offer the advantage of efficient analysis from small samples, eliminating the need for additional sampling. For instance, Illumina’s BaseSpace Informatics Suite enables labs without genomic computing infrastructure to conduct genetic tests and facilitates routine data analysis of sequences through its extensive software library.

In underdeveloped countries with limited access to modern infrastructure, outsourcing becomes a common alternative for immune repertoire sequencing experiments. However, challenges such as poor service quality, extended processing times, and high costs associated with outsourcing may limit market growth.

The rate of market expansion is anticipated to be driven by increased federal funding, the growth of the healthcare industry fueled by both private and public players, and rising utilization of companion diagnostics to enhance treatment safety and efficacy. Additionally, investments in the development of innovative healthcare products, growing awareness of the benefits of multiplex assays, and increased adoption of advanced healthcare technologies contribute to positive market growth prospects, particularly in developing economies.

Leading players in the Next-generation Sequencing Services segment, including Bio-Rad Laboratories, Inc., Congenica Ltd., Theragen Etex Inc., PerkinElmer, Inc., Partek Inc., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Golden Helix, Inc., BioDatomics, Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, and DNA Star, Inc., are expected to play a crucial role in shaping the future landscape of Next-generation Sequencing Services technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Next-generation Sequencing Services market. It also delves into the analysis of present and prospective market competition within the global Next-generation Sequencing Services market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

Develop your business strategies by gaining insights into the trends that shape and drive the Next-generation Sequencing Services market across the 10MM (Ten Major Markets).
Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Next-generation Sequencing Services market.
Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Executive Summary: Next-generation Sequencing Services
- Global Market Outlook: Next-generation Sequencing Services
Competitive Intelligence Analysis: Next-generation Sequencing Services
Therapeutic Sector SWOT
Technology Roadmap Analysis: Next-generation Sequencing Services
Market Background
- Drivers
- Restraints
- Opportunity
- Key Market Trends
- Key Unmet Needs
Key Marketed Products Profile – Major Approved Products: Next-generation Sequencing Services
- Product Profile
- Safety and Efficacy
Regulatory Landscape
Next-generation Sequencing Services: Ten Major Market (10MM) – Market Analysis, By Services
- Human Genome Sequencing Services
- Single Cell Sequencing Services
- Microbial Genome-based Sequencing Services
- Gene Regulation Services
- Animal & Plant Sequencing Services
- Other Sequencing Services
Next-generation Sequencing Services: Ten Major Market (10MM) – Market Analysis, By Technology
- Sequencing by Synthesis (SBS)
- Single-Molecule Real-Time (SMRT) Sequencing
- Nanopore Sequencing
- Others
Next-generation Sequencing Services: Ten Major Market (10MM) – Market Analysis, By End User
- Biopharmaceuticals Companies
- Academic & Research Institutes
- Clinical Research Organizations
- Others
Next-generation Sequencing Services: Ten Major Market (10MM) – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

S. Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

K. Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

Germany Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

France Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

Italy Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

Spain Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

Japan Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

China Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

Australia Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

India Next-generation Sequencing Services – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Services
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Services
  - By Technology
  - By End User

Competitive Landscape
- Company Overview
- Product Portfolio
- Key Financials
- Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

Assumptions and Acronyms Used
Research Methodology
- Secondary Research
- Primary Research
- Data Triangulation
Geographic Scope
- The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
Copyrights and Disclaimer

Next-generation Sequencing Services Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

License Type (Price in USD)

Customize Reports As Per Your Needs

Have A Question?

Phone:+919599779105
Email:info@pacificbusinessconsulting.com

RELATED PRODUCTS

Acute Myeloid Leukemia (AML) Market in United States, United Kingdom – Market Outlook, Market Assessment and Market Forecast (2023-2030)

Alzheimer’s Disease Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Chronic Kidney Disease (CKD) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Chronic Lymphocytic Leukemia (CLL) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Diabetic Neuropathic Pain (DNP) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Useful Links

Consulting

Get In Touch